INTRAHEPATIC OVEREXPRESSION OF FOXO1 IN CIRRHOTIC PATIENTS IS A POTENTIAL MARKER OF LIVER INJURY PROGRESSION

被引：0
|
作者：
Fernandez, Esther [1 ]
Sandalinas, Silvia [1 ]
Macias, Laura [1 ]
Portoles-Plaza, Irene [1 ]
Ribera, Jordi [1 ,2 ]
Morales-Romero, Blai [1 ]
Casals, Gregori [1 ,2 ,3 ]
Boix, Loreto [4 ]
Jimenez Povedano, Wladimiro [1 ,2 ,5 ]
Morales-Ruiz, Manuel [1 ,2 ,3 ,5 ]
机构：
[1] Hosp Clin Barcelona, Idibaps, Serv Biochem & Mol Genet, Barcelona, Spain
[2] Ciberehd, Madrid, Spain
[3] Seqc ML, Commiss Biochem Assessment Hepat Dis, Barcelona, Spain
[4] Univ Barcelona, Hosp Clin, Idibaps,Ciberehd, Barcelona Clin Liver Canc Grp,Liver Unit, Barcelona, Spain
[5] Univ Barcelona, Biomed Sch Med & Hlth Sci, Barcelona, Spain
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3630
引用
收藏
页码：S1148 / S1149
页数：2
相关论文
共 50 条
  • [31] ATRA Regulates Innate Immunity in Liver Ischemia/Reperfusion Injury via RARα/Akt/Foxo1 Signaling
    Zhong, Chen
    Pu, Liyong
    Fang, Mingming
    Rao, Jianhua
    Wang, Xuehao
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (04) : 530 - 535
  • [32] Akt-mediated foxo1 inhibition is required for liver regeneration
    Pauta, Montse
    Rotllan, Noemi
    Fernandez-Hernando, Ana
    Langhi, Cedric
    Ribera, Jordi
    Lu, Mingjian
    Boix, Loreto
    Bruix, Jordi
    Jimenez, Wladimiro
    Suarez, Yajaira
    Ford, David A.
    Baldan, Angel
    Birnbaum, Morris J.
    Morales-Ruiz, Manuel
    Fernandez-Hernando, Carlos
    HEPATOLOGY, 2016, 63 (05) : 1660 - 1674
  • [33] FoxO1 overexpression promotes for the early activation of Akt/mTOR signaling in skeletal myotubes
    Hoover, Rachael
    Steele, Derek
    McLoughlin, Thomas J.
    FASEB JOURNAL, 2011, 25
  • [34] FORKHEAD TRANSCRIPTION FACTOR FOXO1 IS INVOLVED IN PROGRESSION OF RENAL CELL CARCINOMA
    Kojima, Takahiro
    Shimazui, Toru
    Hinotsu, Shiro
    Oikawa, Takehiro
    Kawai, Koji
    Uchida, Kazuhiko
    Akaza, Hideyuki
    JOURNAL OF UROLOGY, 2009, 181 (04): : 106 - 106
  • [35] Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression
    Tang, Guodong
    Liu, Dingyang
    Xiao, Gelei
    Liu, Qing
    Yuan, Jian
    ONCOTARGET, 2016, 7 (49) : 81757 - 81767
  • [36] Genome-wide analysis of FoxO1 binding in hepatic chromatin: Potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis
    Shin, Dong-Ju
    Joshi, Pujan
    Hong, Seung-Hyun
    Mosure, Kathleen
    Shin, Dong-Guk
    Osborne, Timothy F.
    NUCLEIC ACIDS RESEARCH, 2012, 40 (22) : 11499 - 11509
  • [37] Exploring the Potential of Natural Products as FoxO1 Inhibitors : an In Silico Approach
    Gupta, Anugya
    Haldhar, Rajesh
    Agarwal, Vipul
    Rajput, Dharmendra Singh
    Chun, Kyung-Soo
    Han, Sang Beom
    Raj, Vinit
    Lee, Sangkil
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (03) : 390 - 398
  • [38] Overexpression of CD151 as an Adverse Marker for Intrahepatic Cholangiocarcinoma Patients
    Huang, Xiao-Yong
    Ke, Ai-Wu
    Shi, Guo-Ming
    Ding, Zhen-Bin
    Devbhandari, Ranjan Prasad
    Gu, Fang-Ming
    Li, Quan-Lin
    Dai, Zhi
    Zhou, Jian
    Fan, Jia
    CANCER, 2010, 116 (23) : 5440 - 5451
  • [39] Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma
    Cheng, Shih-Ping
    Chen, Ming-Jen
    Chien, Ming-Nan
    Lin, Chi-Hsin
    Lee, Jie-Jen
    Liu, Chien-Liang
    CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 17 (04) : 555 - 564
  • [40] Oxaliplatin reverses the GLP-1R-mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling
    Chen, Bendong
    Zhou, Wenyan
    Zhao, Wenchao
    Yuan, Peng
    Tang, Chaofeng
    Wang, Genwang
    Leng, Junzhi
    Ma, Jinlong
    Wang, Xiaowen
    Hui, Yongfeng
    Wang, Qi
    ONCOLOGY LETTERS, 2019, 18 (02) : 1989 - 1998
12345